Ads
related to: t2d treatment
Search results
Steps to Take When Your Diabetes Treatment No Longer Seems to Be Working
Prevention via Yahoo News· 9 months agoWhen to Refresh Your Type 2 Diabetes Treatment FatCamera - Getty Images It’s likely you’ve gotten...
Eli Lilly’s efsitora alfa shows promise in Phase III T2D trials
Clinical Trials Arena via Yahoo Finance· 2 weeks agoEli Lilly has reported positive outcomes from the Phase III QWINT-2 and QWINT-4 clinical trials of...
What Is Diabetes Mellitus?
Health via Yahoo News· 9 months agoDiabetes mellitus—more commonly known as diabetes—is a chronic disease that occurs when you have higher than normal levels of blood glucose (or, blood...
Better Therapeutics Seeks FDA Approval For First Digital Therapeutic For Type 2 Diabetes
Benzinga via Yahoo Finance· 2 years agoBetter Therapeutics Inc (NASDAQ: BTTX) has submitted a de novo classification request to the FDA...
5 Common Misconceptions About Type 1 Diabetes Risk
Women's Health via Yahoo News· 7 months ago5 Common Misconceptions About Type 1 Diabetes RiskGetty Images Diabetes is increasing at an alarming rate—which could be why myths and misconceptions...
Novo Nordisk's (NVO) Shares Jump 17% in a Month: Here's Why
Zacks via Yahoo Finance· 9 months agoShares of Novo Nordisk NVO have risen 17.1% in the past month compared with the industry’s 5.0%...
Why Better Therapeutics Shares Are Surging During Premarket Session
Benzinga via Yahoo Finance· 2 years agoBetter Therapeutics Inc (NASDAQ: BTTX) completed the pivotal clinical trial for BT-001, an...
Lilly (LLY) Gets FDA Nod for Pediatric Use of Diabetes Drugs
Zacks via Yahoo Finance· 11 months agoFollowing FDA's label expansion approval, Lilly's (LLY) Jardiance and Synjardy are the first SGLT2...
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
Zacks via Yahoo Finance· 2 weeks agoEli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their...
Novo Nordisk (NVO) Down Despite Kidney Outcomes Study Success
Zacks via Yahoo Finance· 3 months agoNovo Nordisk (NVO) declines 3% despite achieving the primary endpoint with statistical significance...
Ads
related to: t2d treatment